Blackstone

Money Moves

Agreed to buy about 16% of IIFL Finance through an affiliate

IIFL Finance lends against gold and to small businesses from more than 5,000 branches across India. On November 10 its board approved a ₹6,414 crore capital raise, with Blackstone paying ₹5,000 crore, about $535 million, for a 15.57% fully diluted stake.

Updated Yesterday

Money Moves

Providing $1 billion in structured equity

Shield AI agreed to buy Echodyne, a Kirkland, Washington, radar maker, for $4.8 billion at closing and up to $500 million more if the company hits performance targets. The deal, announced Nov. 5, is Shield's fifth acquisition and its largest.

Updated 4 days ago

Money Moves

Owner of AirTrunk since 2024

AirTrunk borrowed A$4.25 billion (US$2.98 billion) to keep building SYD3, a 400-megawatt data centre campus in Western Sydney due online by mid-2028. The green loan, one of Australia's largest data centre financings, is backed by 32 financial institutions.

Updated Oct 29

Money Moves

Largest debt and equity backer of Firmus

Firmus pulled its $5 billion Australian listing on October 9 after investors balked at a $30.6 billion valuation for a company that has built 46 megawatts of a 912-megawatt pipeline. Nvidia is now weighing hundreds of millions of dollars in fresh support as Firmus tries to raise $2-3 billion privately.

Updated Oct 25

Money Moves

As of August 2026: Selling owner of Precision Medicine Group

The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.

Updated Aug 26

Money Moves

As of July 2026: Seller (majority owner)

Hungary's biggest bank just bought its way into a region it has never operated in. On July 20, 2026, OTP Bank signed a deal to acquire 100% of Luminor, the third-largest banking group in the Baltics. It is the largest acquisition in OTP's history.

Updated Jul 20

Money Moves

As of May 2026: Controlling sponsor; positioned for long-delayed liquidity through public markets

Medline's Nasdaq arrival as MDLN quickly turned from “biggest IPO of 2025” into a live market verdict. Shares jumped roughly 41% in their first session, pushing the company into a roughly $50B+ valuation almost immediately.

Updated May 15